Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same

Details for Australian Patent Application No. 2001255543 (hide)

Owner University of Maryland, Baltimore

Inventors Barry, Eileen M.; Levine, Myron M.; Altboum, Zeev

Agent Fisher Adams Kelly

Pub. Number AU-B-2001255543

PCT Pub. Number WO01/81582

Priority 60/198,626 20.04.00 US

Filing date 20 April 2001

Wipo publication date 7 November 2001

Acceptance publication date 23 June 2005

International Classifications

C12N 015/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 039/108 Medicinal preparations containing antigens or antibodies - Escherichia

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 014/245 Peptides having more than 20 amino acids

Event Publications

7 August 2003 Amendment Made

  The nature of the amendment is: Amend the priority details from US 60/198,686 20/4/00 to US 60/198,626 20/4/00

23 June 2005 Application Accepted

  Published as AU-B-2001255543

20 October 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001255544

2001255542